Real-World Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis.

Beatriz GrosMairi GoodallNik PlevrisNathan Constantine-Cooke Alexander Thomas ElfordClaire O'HareColin NobleGareth-Rhys JonesIan D ArnottCharlie W Lees

Published in: Journal of Crohn's & colitis (2023)

These are the first reported data on the real-world efficacy and safety of filgotinib in ulcerative colitis. Our findings demonstrate that filgotinib is an effective and low risk treatment option for these patients.

Keyphrases

ulcerative colitis
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
big data
machine learning
deep learning
artificial intelligence
smoking cessation
replacement therapy